These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20505189)

  • 1. NF1 inactivation in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Wang Y; Liu Y; Wright W; Roulston D; Purkayastha A; Dressel A; Karp J; Bockenstedt P; Al-Zoubi A; Talpaz M; Kujawski L; Liu Y; Shedden K; Shakhan S; Li C; Erba H; Malek SN
    Clin Cancer Res; 2010 Aug; 16(16):4135-47. PubMed ID: 20505189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF1 inactivation revs up Ras in adult acute myelogenous leukemia.
    Mullally A; Ebert BL
    Clin Cancer Res; 2010 Aug; 16(16):4074-6. PubMed ID: 20587590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.
    Parkin B; Erba H; Ouillette P; Roulston D; Purkayastha A; Karp J; Talpaz M; Kujawski L; Shakhan S; Li C; Shedden K; Malek SN
    Blood; 2010 Dec; 116(23):4958-67. PubMed ID: 20729466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
    Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
    Boudry-Labis E; Roche-Lestienne C; Nibourel O; Boissel N; Terre C; Perot C; Eclache V; Gachard N; Tigaud I; Plessis G; Cuccuini W; Geffroy S; Villenet C; Figeac M; Leprêtre F; Renneville A; Cheok M; Soulier J; Dombret H; Preudhomme C;
    Am J Hematol; 2013 Apr; 88(4):306-11. PubMed ID: 23460398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.
    Cutts BA; Sjogren AK; Andersson KM; Wahlstrom AM; Karlsson C; Swolin B; Bergo MO
    Blood; 2009 Oct; 114(17):3629-32. PubMed ID: 19710506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
    García-Ortí L; Cristóbal I; Cirauqui C; Guruceaga E; Marcotegui N; Calasanz MJ; Castello-Cros R; Odero MD
    PLoS One; 2012; 7(10):e47717. PubMed ID: 23077663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.
    Kalra R; Paderanga DC; Olson K; Shannon KM
    Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
    Balgobind BV; Van Vlierberghe P; van den Ouweland AM; Beverloo HB; Terlouw-Kromosoeto JN; van Wering ER; Reinhardt D; Horstmann M; Kaspers GJ; Pieters R; Zwaan CM; Van den Heuvel-Eibrink MM; Meijerink JP
    Blood; 2008 Apr; 111(8):4322-8. PubMed ID: 18172006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
    Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
    Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
    Int J Cancer; 2014 Jan; 134(1):55-64. PubMed ID: 23797738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
    Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
    Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
    Al-Mawali A; Pinto AD; Al-Zadjali S
    Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
    Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
    Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
    Quesnel B; Preudhomme C; Vanrumbeke M; Vachee A; Lai JL; Fenaux P
    Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome.
    Eisfeld AK; Kohlschmidt J; Mrózek K; Mims A; Walker CJ; Blachly JS; Nicolet D; Orwick S; Maharry SE; Carroll AJ; Powell BL; Kolitz JE; Wang ES; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Leukemia; 2018 Dec; 32(12):2536-2545. PubMed ID: 29872168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
    Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
    Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation Screening of Her-2, N-ras and Nf1 Genes in Brain Tumor Biopsies.
    Yapijakis C; Adamopoulou M; Tasiouka K; Voumvourakis C; Stranjalis G
    Anticancer Res; 2016 Sep; 36(9):4607-11. PubMed ID: 27630302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.